Country: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Acebutolol hydrochloride
Neon Healthcare Ltd
C07AB04
Acebutolol hydrochloride
200mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000; GTIN: 5036850013162
PACKAGE LEAFLET: INFORMATION FOR THE USER SECTRAL 400MG TABLETS SECTRAL 100MG AND 200MG CAPSULES Acebutolol (as hydrochloride) Is this leaflet hard to see or read? Phone 0800 198 5000 for help READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Sectral is and what it is used for 2. What you need to know before you take Sectral 3. How to take Sectral 4. Possible side effects 5. How to store Sectral 6. Contents of the pack and other information 1. WHAT SECTRAL IS AND WHAT IT IS USED FOR 1. The name of your medicine is Sectral 400mg Tablets, Sectral 100mg Capsules or Sectral 200mg Capsules (called Sectral throughout this leaflet). This belongs to a group of medicines called beta-blockers. It works by slowing your heart rate or lowering your blood pressure. Sectral is used for: • Chest pain (angina) • High blood pressure • Uneven or unusually fast heart beats (arrhythmia) 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SECTRAL DO NOT TAKE SECTRAL: if you are allergic to acebutolol hydrochloride, other beta-blockers or any of the other ingredients of this medicine (listed in section 6) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue if you have low blood pressure if you have severe heart problems or heart failure not controlled by medicines if you have a very slow heartbeat - less than 50 beats per minute if your doctor has told you that you have an abnormal level of acid in your blood (called acidosis) if you have serious blood circulation problems if you have an tumo Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sectral 200mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 222mg of the active substance Acebutolol hydrochloride (equivalent to 200mg of base). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Capsule Hard gelatin capsules, the bodies being opaque yellowish-buff and the caps opaque pink in colour. Length approximately 17mm, diameter of body approximately 6mm. Both body and cap are printed in black: Sectral or ACB 200 200 The capsules contain a white or almost white powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The management of all grades of hypertension, angina pectoris and the control of tachyarrhythmias. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Hypertension: Initial dosage of 400mg orally once daily at breakfast or 200mg orally twice daily. If response is not adequate within two weeks, dosage may be increased up to 400mg orally twice daily; if the hypertension is still not adequately controlled consideration should be given to adding a second antihypertensive agent such as the calcium antagonist nifedipine or small doses of a thiazide diuretic. Angina pectoris: Initial dosage of 400mg orally once daily at breakfast or 200mg twice daily. In severe forms up to 300mg three times daily may be required. Up to 1200mg daily has been used. Cardiac Arrhythmias: When given orally, an initial dose of 200mg is recommended. The daily dose requirement for long term anti arrhythmic activity should lie between 400 and 1200mg daily. The dose can be gauged by response, and better control may be achieved by divided doses rather than single doses. It may take up to three hours for maximal anti-arrhythmic effect to become apparent. Elderly: There are no specific dosage recommendations for the elderly with normal glomerular filtration rate. Dose reduction is necessary if moderate to severe renal impairment is present (see section 4.4.). Children: Paediatric dose has not been established. For all indicat Lestu allt skjalið